Yahoo · Oct 26, 2026
Novozymes (CPSE:NSIS B) Stock Looks Reasonable After Its 64% Run
Novozymes has rewarded shareholders with a solid run in recent years, which naturally raises a simple question for anyone looking at the chart today. Is the current share price still in line with the cash flows the business is expected to generate, or has sentiment moved ahead of the underlying economics? Over the past 3 years, Novozymes has delivered a 63.7% return, which puts real pressure on the numbers to show that cash generation can support that kind of share price progress. The group...

